950 F Street, N.W.
Washington, DC 20004

+1 202 721 5417

Litigation Star


District of Columbia

Practice area:

Intellectual property

Aziz Burgy is a partner at Axinn and is a registered patent attorney with nearly two decades of patent litigation and trial experience, serving as lead counsel to clients in numerous venues. Mr. Burgy’s practice is focused on life sciences, particularly pharmaceuticals, medical devices and biotechnology. With respect to pharmaceuticals, Mr. Burgy is a savvy and seasoned Hatch-Waxman practitioner, having litigated over 70 such cases in the past 10 years. Although many of his cases have focused on pharmaceuticals, he has also represented clients in the banking, medical device, internet security, robotics, software and GPS technology industries and has handled other IP matters beyond patent disputes, including trademark and copyright cases.

Before attending law school, Mr. Burgy worked as a research associate at MedImmune Inc. During his time there, Mr. Burgy was awarded the Chairman’s Award, in part, for his work on the development of a humanized monoclonal antibody (palivizumab) with activity against respiratory syncytial virus and a vaccine consisting of self-assembling, virus-like particles for the prevention of human papillomavirus (HPV) infection. His industry experience, advanced life sciences coursework and his extensive legal experience provide him with the technical and legal expertise necessary to successfully represent his clients in scientifically complex matters.

Mr. Burgy is a frequent lecturer on US IP rights. He regularly lectures at industry conferences and teaches classes on intellectual property at the University of North Carolina at Chapel Hill. Not only is Mr. Burgy at the forefront of patent jurisprudence, he has also helped shape legislation related to patent laws. Specifically, Mr. Burgy has advised clients and Congress on various patent legislation matters dealing with the America Invents Act.

Mr. Burgy earned his BS in biology from University of North Carolina at Chapel Hill, an MS in biotechnology from Johns Hopkins University and his JD from the University of New Hampshire.

Updated Sep 2023